FDA Advisory Committee Rejects Vivus Inc. Weight Loss Pill

July 19th, 2010 - 7:42 pm ICT by GD  

By Gina Gomez
pillGaithersburg,July 19, (THAINDIAN NEWS) Vivus Inc., the pharmaceutical company that manufactures the anti-obesity drug Qnexa suffered a major setback on Thursday when the a panel of federal health officials rejected the pill after they found that the side-effects of the drug were far more significant in comparison to its ability to shed weight. The advisory committee stated in very clear terms that although the drug appears to be able to make people lose weight, side-effects of the drug indeed seem to pose a major threat to the individuals administering it.

The members of the panel of federal health experts agreed unanimously to the pills ability to help people lose the additional calories. However, the benefits of the drug was overshadowed by a huge array of safety concerns that emerged during the company trials. According to the panelists, the side-effects that are likely to surface on administration of the weight-loss pills include memory lapses, suicidal tendencies, birth defects as well heart palpitation. Kenneth Burman who chaired the panel and is associated with the Washington Hospital Center revealed to the media that some of the side-effects are extremely serious and could also be life-threatening.

Meanwhile, the Food and Drug Administration panel has voted 10-6 against the weight-loss drug explaining that it was uncertain about the potential risk that the pill might pose to the patients who might administer it in a long term basis. The decision of the panel might come as a major blow to the drug maker Vivus Inc. which is pitching the drug as the first U.S. prescription weight loss drug in over a decade.

Related Stories

Tags: , , , , , , , , , , , , , , , , , , ,

Posted in Health |

Subscribe